Hyftor™ (sirolimus) – New drug approval
March 22, 2022 - FDA approved Nobelpharma’s Hyftor (sirolimus) topical gel, for the treatment of facial angiofibroma associated with tuberous sclerosis in adults and pediatric patients 6 years of age and older.
Download PDF
